SAA1 and non-small cell lung carcinoma: Serum amyloid A protein 1 (SAA1) was higher expressed in the plasma of the NSCLC patients who poorly responded to gefitinib treatment, in which case SAA1 generated four out of the eight MS mass signals composing the VeriStrat algorithm.